- Home
- AUGO vs ICLR Comparison
AUGO vs ICLR Comparison
Compare AUGO & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUGO | ICLR |
|---|---|---|
| Founded | 1946 | 1990 |
| Country | United States | Ireland |
| Employees | 1462 | 41900 |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.2B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | AUGO | ICLR |
|---|---|---|
| Price | $108.47 | $113.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $67.60 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 996.0K | 753.1K |
| Earning Date | 05-19-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $90.40 | N/A |
| Revenue Next Year | $18.06 | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.55 | $66.57 |
| 52 Week High | $105.14 | $211.00 |
Technical Indicators
Market Signals| Indicator | AUGO | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 75.52 | 56.07 |
| Support Level | $62.16 | $95.75 |
| Resistance Level | N/A | $114.75 |
| Average True Range (ATR) | 4.83 | 5.11 |
| MACD | 3.25 | 1.65 |
| Stochastic Oscillator | 98.31 | 85.83 |
Price Performance
Historical ComparisonAbout AUGO Aura Minerals Inc.
Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.